Background Incomplete adherence to tuberculosis (TB) treatment increases the risk of
delayed culture conversion with continued transmission in the community, as well as …

Background The development of drug-resistant (DR) tuberculosis (TB) has become an
increasing concern over the past few decades as the result of numerous factors, including …

The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …

The objectives of the 2022 consolidated guidelines are: to provide policy makers and
implementing partners with evidence-based recommendations on the cascade of care for …

In order to support countries in their effort to respond to the challenges posed by the TB
epidemic over the years, WHO has produced and regularly updated guidelines for the …

Given shortages of health care providers and a rise in the number of people living with both
communicable and non-communicable diseases, Community Health Workers (CHWs) are …

Background Transmission dynamics, vectorial capacity, and co-infections have substantial
impacts on vector-borne diseases (VBDs) affecting urban and suburban populations …

Background Poor adherence to tuberculosis (TB) treatment can lead to prolonged infectivity
and poor treatment outcomes. Directly observed treatment (DOT) seeks to improve …

Introduction Ethiopia is among the high-burden countries for tuberculosis (TB), TB/HIV, and
drug-resistant TB. The aim of this nationwide study was to better understand TB-related …